| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 医药工业(元) | - | 6,562,014,200.00 | 11,912,272,900.00 | 6,472,432,800.00 |
| 医药商业(元) | - | 6,054,614,500.00 | 11,230,407,600.00 | 6,030,351,000.00 |
| 行业间抵消(元) | -4,151,893,000.00 | -2,946,112,600.00 | -4,782,126,000.00 | - |
| 医药工业主营业务(元) | 10,717,829,700.00 | - | - | - |
| 医药商业主营业务(元) | 10,477,753,800.00 | - | - | - |
| 其他行业(元) | - | 44,427,900.00 | 127,018,200.00 | - |
| 其他行业主营业务(元) | 114,052,600.00 | - | - | - |
| 营业成本(元) | ||||
| 医药工业(元) | - | 3,675,108,400.00 | 6,700,908,500.00 | 3,793,474,500.00 |
| 医药商业(元) | - | 4,459,391,300.00 | 8,153,979,900.00 | 4,421,842,300.00 |
| 行业间抵消(元) | -3,981,160,000.00 | -2,742,066,800.00 | -4,576,658,000.00 | - |
| 医药工业主营业务(元) | 6,084,359,700.00 | - | - | - |
| 医药商业主营业务(元) | 7,624,940,200.00 | - | - | - |
| 其他行业(元) | - | 39,322,800.00 | 117,090,200.00 | - |
| 其他行业主营业务(元) | 104,567,600.00 | - | - | - |
| 毛利(元) | ||||
| 医药工业(元) | - | 2,886,905,800.00 | 5,211,364,400.00 | 2,678,958,300.00 |
| 医药商业(元) | - | 1,595,223,200.00 | 3,076,427,700.00 | 1,608,508,700.00 |
| 行业间抵消(元) | -170,733,000.00 | -204,045,800.00 | -205,468,000.00 | - |
| 医药工业主营业务(元) | 4,633,470,000.00 | - | - | - |
| 医药商业主营业务(元) | 2,852,813,600.00 | - | - | - |
| 其他行业(元) | - | 5,105,100.00 | 9,928,000.00 | - |
| 其他行业主营业务(元) | 9,485,000.00 | - | - | - |
| 毛利率(%) | ||||
| 医药工业(%) | - | 43.99 | 43.75 | 41.39 |
| 医药商业(%) | - | 26.35 | 27.39 | 26.67 |
| 行业间抵消(%) | 4.11 | 6.93 | 4.30 | - |
| 医药工业主营业务(%) | 43.23 | - | - | - |
| 医药商业主营业务(%) | 27.23 | - | - | - |
| 其他行业(%) | - | 11.49 | 7.82 | - |
| 其他行业主营业务(%) | 8.32 | - | - | - |
| 收入构成(%) | ||||
| 医药工业(%) | - | 67.55 | 64.43 | 51.77 |
| 医药商业(%) | - | 62.32 | 60.75 | 48.23 |
| 行业间抵消(%) | -24.20 | -30.33 | -25.87 | - |
| 医药工业主营业务(%) | 62.47 | - | - | - |
| 医药商业主营业务(%) | 61.07 | - | - | - |
| 其他行业(%) | - | 0.46 | 0.69 | - |
| 其他行业主营业务(%) | 0.66 | - | - | - |
| 毛利构成(%) | ||||
| 医药工业(%) | - | 67.40 | 64.40 | 62.48 |
| 医药商业(%) | - | 37.24 | 38.02 | 37.52 |
| 行业间抵消(%) | -2.33 | -4.76 | -2.54 | - |
| 医药工业主营业务(%) | 63.26 | - | - | - |
| 医药商业主营业务(%) | 38.95 | - | - | - |
| 其他行业(%) | - | 0.12 | 0.12 | - |
| 其他行业主营业务(%) | 0.13 | - | - | - |